Livforsakringsbolaget Skandia’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,772
| Closed | -$78.5K | – | 553 |
|
|
2025
Q1 | $78.5K | Hold |
2,772
| – | – | ﹤0.01% | 515 |
|
|
2024
Q4 | $115K | Hold |
2,772
| – | – | 0.01% | 482 |
|
|
2024
Q3 | $185K | Buy |
2,772
+2,039
| +278% | +$136K | 0.01% | 434 |
|
|
2024
Q2 | $87K | Hold |
733
| – | – | 0.01% | 309 |
|
|
2024
Q1 | $78.1K | Hold |
733
| – | – | 0.01% | 341 |
|
|
2023
Q4 | $72.9K | Sell |
733
-3,867
| -84% | -$385K | 0.01% | 344 |
|
|
2023
Q3 | $475K | Hold |
4,600
| – | – | 0.05% | 207 |
|
|
2023
Q2 | $559K | Sell |
4,600
-400
| -8% | -$48.6K | 0.06% | 205 |
|
|
2023
Q1 | $768K | Hold |
5,000
| – | – | 0.08% | 193 |
|
|
2022
Q4 | $898K | Hold |
5,000
| – | – | 0.1% | 168 |
|
|
2022
Q3 | $591K | Sell |
5,000
-2,400
| -32% | -$284K | 0.07% | 183 |
|
|
2022
Q2 | $1.06M | Sell |
7,400
-800
| -10% | -$114K | 0.09% | 166 |
|
|
2022
Q1 | $1.41M | Hold |
8,200
| – | – | 0.09% | 164 |
|
|
2021
Q4 | $2.08M | Sell |
8,200
-1,300
| -14% | -$330K | 0.13% | 146 |
|
|
2021
Q3 | $3.66M | Sell |
9,500
-800
| -8% | -$308K | 0.23% | 102 |
|
|
2021
Q2 | $2.42M | Buy |
10,300
+3,600
| +54% | +$846K | 0.14% | 140 |
|
|
2021
Q1 | $877K | Buy |
6,700
+2,500
| +60% | +$327K | 0.06% | 239 |
|
|
2020
Q4 | $439K | Buy |
4,200
+2,100
| +100% | +$220K | 0.04% | 331 |
|
|
2020
Q3 | $149K | Sell |
2,100
-1,900
| -48% | -$135K | 0.02% | 452 |
|
|
2020
Q2 | $257K | Buy |
+4,000
| New | +$257K | 0.03% | 338 |
|